RARE
Ultragenyx Pharmaceutical Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Ultragenyx Pharmaceutical Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Ultragenyx Pharmaceutical Inc.
16.10
−0.68 · −4.05%
post 16.06 −0.25%
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $355.7M | 9.67% | +45.96% | |
| 2 | RTW InvestmentsRTW | $260.3M | 7.08% | +113.68% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $226.7M | 6.17% | +26.07% | |
| 4 | AQR Capital ManagementAQR | $214.1M | 5.82% | +43.31% | |
| 5 | State StreetState Streetindex-like | $205.6M | 5.59% | +22.65% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $143.5M | 3.90% | +2.55% | |
| 7 | Two Sigma InvestmentsTwo Sigma | $120.9M | 3.29% | +64.17% | |
| 8 | Sands Capital ManagementSands | $105.5M | 2.87% | −1.75% | |
| 9 | Jacobs Levy Equity ManagementJacobs Levy Equity | $98.2M | 2.67% | +105.42% | |
| 10 | Frontier Capital ManagementFrontier | $95.1M | 2.59% | +29.97% | |
| 11 | Geode Capital ManagementGeodeindex-like | $86.1M | 2.34% | +39.44% | |
| 12 | Sofinnova InvestmentsSofinnova | $74.0M | 2.01% | −36.57% | |
| 13 | Bellevue GroupBellevue | $66.2M | 1.80% | −16.69% | |
| 14 | D. E. ShawD. E. Shaw | $57.8M | 1.57% | +37.21% | |
| 15 | Adage Capital Partners GPAdage Capital Partners GP | $52.8M | 1.43% | +229.17% | |
| 16 | GW&K Investment ManagementGW&K | $49.5M | 1.34% | −8.31% | |
| 17 | MPM Oncology Impact ManagementMPM Oncology Impact | $47.4M | 1.29% | new | |
| 18 | T. Rowe Price AssociatesT. Rowe Price | $45.3M | 1.23% | +68.70% | |
| 19 | Morgan StanleyMorgan Stanley | $44.2M | 1.20% | −11.71% | |
| 20 | Caption ManagementCaption | $42.1M | 1.14% | +70.36% | |
| 21 | Wellington Management GroupWellington | $41.8M | 1.14% | −52.65% | |
| 22 | Voloridge Investment ManagementVoloridge | $41.5M | 1.13% | −12.99% | |
| 23 | Bank of AmericaBank of America | $38.3M | 1.04% | +9.74% | |
| 24 | Candriam Luxembourg S.C.A.Candriam Luxembourg S.C.A. | $33.4M | 0.91% | −8.61% | |
| 25 | Rock Springs Capital ManagementRock Springs | $32.3M | 0.88% | −20.59% |
317 managers report $3.7B of Ultragenyx Pharmaceutical on form 13F for the quarter ended Jun 30 '26. 40 of them hold 80% of it; BlackRock is largest at 9.67%.
Expected move
Inputsspot 16.10exp Nov 6ATM strike 16ATM straddle 1.67IV 94%